Jan 11, 2023 / 10:15PM GMT
Steve Tuekam - JPMorgan Chase & Co. - Analyst
Good afternoon, everyone, and thank you for joining us today. My name is Steve Tuekam, and I'm an associate with JPMorgan's Healthcare Investment Banking team. (Opperator Instructions) Today, I'm pleased to introduce John Fowler, Co-Founder and CEO of Kezar Life Sciences. I'm sure he is excited to tell me more about the company and the work his especially the team has been doing to deliver unique treatments that can better the lives of patients fighting difficult to treat chronic diseases.
And with that, I'll pass it over to John to share the story. Thank you.
John Fowler - Kezar Life Sciences, Inc. - CEO, co-Founder
Thanks, very much, and that's really good to be here. Thanks, everybody, for taking the time at the -- near the end of a long day and a long week to learn a little bit about Kezar Life Sciences. I've got a slide deck that will take about 20, 25 minutes to get through. Definitely happy to take questions. I'm joined by my Chief Scientific and Chief Medical Officer is here as well. So if you
Kezar Life Sciences Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot